Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.51 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.51 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6400603 | 1.00 | L3MBTL1 (0.58) | L3MBTL1BLMNPSR1TSHRLMNA | |
| SCHEMBL503788 | 1.00 | L3MBTL1 (0.58) | L3MBTL1BLMNPSR1TSHRLMNA | |
| Mandelic Acid SCHEMBL2010439 | 0.86 | L3MBTL1 (0.52) | L3MBTL1LMNAMAPK1AOC3MTNR1A | |
| SCHEMBL22625898 | 0.86 | L3MBTL1 (0.58) | L3MBTL1AOC3MTNR1AMTNR1BCES2 | |
| SCHEMBL6402645 | 0.84 | PTGS1 (0.53) | BLMNPSR1TSHRLMNAMAPK1 | |
| SCHEMBL5527572 | 0.84 | L3MBTL1 (0.65) | L3MBTL1AOC3MTNR1AMTNR1BCES2 | |
| SCHEMBL11081245 | 0.84 | L3MBTL1 (0.56) | L3MBTL1AOC3MTNR1AMTNR1BCES2 | |
| SCHEMBL6396089 | 0.84 | PTGS1 (0.53) | BLMNPSR1TSHRLMNAMAPK1 | |
| SCHEMBL6396086 | 0.84 | PTGS1 (0.53) | BLMNPSR1TSHRLMNAMAPK1 | |
| SCHEMBL2871628 | 0.84 | L3MBTL1 (0.56) | L3MBTL1AOC3MTNR1AMTNR1BCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109467502-B | Method for splitting mandelic acid compound enantiomer | 湖南科技大学 | 2021-07-30 | — | — | CN | claimed |
| EP-3141284-B1 | METHOD OF STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | OREAL (FR) | 2019-08-28 | — | — | EP | claimed |
| EP-2029237-B1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | ORÉAL L (FR) | 2016-10-12 | — | — | EP | claimed |
| US-20160074296-A1 | METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN a-HYDROXY ACID DERIVATIVE | L'OREAL (FR) | 2016-03-17 | — | — | US | claimed |
| US-20130139844-A1 | METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN ¤-HYDROXY ACID DERIVATIVE | L'OREAL S.A. (FR) | 2013-06-06 | — | — | US | claimed |
| US-20100300471-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | L'OREAL S.A. (FR) | 2010-12-02 | — | — | US | claimed |
| EP-3893834-B1 | STRAIGHTENING PROCESS FOR KERATIN FIBERS | OREAL (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-12324849-B2 | Process for reshaping keratin fibers | L'OREAL (FR) | 2025-06-10 | — | — | US | disclosed |
| EP-3843696-B1 | PROCESS AND COMPOSITION FOR COLORING KERATIN FIBERS | OREAL (FR) | 2025-04-09 | — | — | EP | disclosed |
| EP-3694475-B1 | PROCESS FOR RESHAPING KERATIN FIBERS | OREAL (FR) | 2025-01-22 | — | — | EP | disclosed |
| US-20240269050-A1 | ELECTROPORATION PROCESS FOR DELIVERING A COMPOSITION COMPRISING AT LEAST ONE HYDROXY ACID COMPOUND | L'OREAL (FR) | 2024-08-15 | — | — | US | disclosed |
| WO-2024122393-A1 | COMPOSITION FOR IMPROVED STRAIGHTENING OF KERATIN FIBERS | L'OREAL (FR) | 2024-06-13 | — | — | WO | disclosed |
| WO-2023110815-A1 | EMULSION WITH ALPHA-HYDROXY ACID, UV FILTER AND POLYMER | L'OREAL (FR) | 2023-06-22 | — | — | WO | disclosed |
| US-4218380-A | OXIDATION OF THE A-HYDROXY-ARYLACETIC ACID | BAYER AKTIENGESELLSCHAFT (DE) | 1980-08-19 | — | — | US | disclosed |
| US-4202699-A | Lithoplates of quaternary ammonium salt compositions | VICKERS LIMITED (GB) | 1980-05-13 | — | — | US | disclosed |
| US-4126468-A | Radiation sensitive compositions of quaternary ammonium salt and carboxylic acid sensitizer | VICKERS LIMITED (GB) | 1978-11-21 | — | — | US | disclosed |
| US-4018759-A | BACTERICIDES | SMITHKLINE CORPORATION (US) | 1977-04-19 | — | — | US | disclosed |
| US-3957768-A | BACTERICIDES | SMITHKLINE CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
| US-3946005-A | BACTERICIDES | SMITHKLINE CORPORATION (US) | 1976-03-23 | — | — | US | disclosed |
| US-3943129-A | BACTERICIDE | SMITHKLINE CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100300471-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN ACID DERIVATIVE | KRT18, KLK5, HOGA1 | L3MBTL1 4874/4885BLM 4293/4885NPSR1 4620/4885 |
| US-12324849-B2 | Process for reshaping keratin fibers | KRT18, CD44, COL14A1 | L3MBTL1 4628/4885BLM 1284/4885NPSR1 4854/4885 |
| US-20160074296-A1 | METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN a-HYDROXY ACID DERIVATIVE | KRT18, HOGA1, CYP27B1 | L3MBTL1 4870/4885BLM 4667/4885NPSR1 4027/4885 |
| US-20130139844-A1 | METHOD FOR STRAIGHTENING HUMAN HAIR FIBERS USING HEATING MEANS AND AN ¤-HYDROXY ACID DERIVATIVE | KRT18, HOGA1, CYP27B1 | L3MBTL1 4871/4885BLM 4467/4885NPSR1 4297/4885 |
| US-20240269050-A1 | ELECTROPORATION PROCESS FOR DELIVERING A COMPOSITION COMPRISING AT LEAST ONE HYDROXY ACID COMPOUND | KRT18, CD44, EPCAM | L3MBTL1 4880/4885BLM 4392/4885NPSR1 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.